Sales and prescriptions of generic drug products through Canadian retailpharmacies grew at a faster rate than those of brand-name drugs in 1996, according to IMS Canada, which adds that the number of brand-name prescriptions dispensed last year actually declined.
In each of the past four years, generic prescription drug sales have consistently outpaced their brand-name counterparts, says IMS. During 1996, the dollar volume of generic sales to retail pharmacies increased 21.1% over 1995, compared to 1.5% growth for branded drugs. Sales growth for the entire prescription sector in 1996 was 4.4%, of which generics took 17% and brand-name products 83%. As recently as 1991, generics accounted for only 11% of the market.
Generic drug prescriptions dispensed by retail pharmacies in 1996 rose 8.9%, while brand-name prescriptions fell 0.8%. Total prescriptions rose 2.8% to 233.8 million. Generics now represent 39.8% of prescriptions, while brand-name prescriptions account for 60.2%.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze